|
US2012276185A1
|
|
Soluble implantable device comprising polyelectrolyte with hydrophobic counterions
|
|
US2013259921A1
|
|
Treatment Of Diabetic Patients With A Stent And An Adjunctive Drug Formulation
|
|
US2013261722A1
|
|
Treatment of diabetic patients with a stent and locally administered adjunctive therapy
|
|
US2013224255A1
|
|
Treatment of diabetic patients with a drug eluting stent and adjunctive therapy
|
|
US2011027336A1
|
|
Coatings for implantable devices comprising polymers of lactic acid and methods for fabricating the same
|
|
US2011066223A1
|
|
Bioabsorbable Stent With Time Dependent Structure And Properties
|
|
US2010198330A1
|
|
Bioabsorbable Stent And Treatment That Elicits Time-Varying Host-Material Response
|
|
US2010330147A1
|
|
Drug delivery compositions including nanoshells for triggered drug release
|
|
US2009297575A1
|
|
Implantable drug delivery devices having alternating hydrophilic and amphiphilic polymer layers
|
|
US2011129514A1
|
|
Hygroscopic coating on a balloon device
|
|
US2008147165A1
|
|
Stent fabricated from polymer composite toughened by a dispersed phase
|
|
US2010100169A1
|
|
Medical devices containing biobeneficial particles
|
|
US2008008739A1
|
|
Phase-separated block copolymer coatings for implantable medical devices
|
|
US2008305141A1
|
|
Freeze-thaw method for modifying stent coating
|
|
US2007286885A1
|
|
Copolymer comprising elastin pentapeptide block and hydrophilic block, and medical device and method of treating
|
|
US2008124372A1
|
|
Morphology profiles for control of agent release rates from polymer matrices
|
|
US2007148251A1
|
|
Nanoparticle releasing medical devices
|
|
US2007128246A1
|
|
Solventless method for forming a coating
|
|
US2006078588A1
|
|
Biocompatible coatings for stents
|
|
US2007055364A1
|
|
Controlled disintegrating implantable medical devices
|
